Bispecific Antibodies in Multiple Myeloma | Dana-Farber Cancer Institute

Sdílet
Vložit
  • čas přidán 3. 02. 2023
  • Omar Nadeem, MD, explains bispecific antibodies as an exciting new immunotherapy treatment option for patients with relapsed or refractory multiple myeloma. Learn more about our Multiple Myeloma Program. www.dana-farber.org/multiple-...
  • Věda a technologie

Komentáře • 1

  • @petersampson5202
    @petersampson5202 Před rokem +2

    DEAR EVERYONE AT DANA-FARBER CANCER INSTITUTE,
    HAPPY NEW YEAR.
    GOD BLESS YOU MY FRIENDS. I AM VERY PROUD OF YOU AND VERY HAPPY FOR YOU. I HOPE ALL OF YOUR DREAMS COME TRUE. I LOVE YOU. I LOVE DANA-FARBER CANCER INSTITUTE. 🙏
    SINCERELY PETER